Journal of Vascular Surgery
Volume 50, Issue 6 , Pages 1500-1510 , December 2009

Current evidence and clinical implications of aspirin resistance

  • George Kasotakis, MD

      Affiliations

    • Department Surgery, Creighton University Medical Center, Omaha, Neb
    • ,
  • Iraklis I. Pipinos, MD

      Affiliations

    • Division of Vascular Surgery, University of Nebraska Medical Center, Omaha, Neb
    • ,
  • Thomas G. Lynch, MD

      Affiliations

    • Division of Vascular Surgery, University of Nebraska Medical Center, Omaha, Neb
    • Corresponding Author InformationReprint requests: Thomas G. Lynch, MD, University of Nebraska Medical Center, Department of Surgery, 983280 Nebraska Medical Center, Omaha, NE 68198-3280

Received 20 March 2009 ,Accepted 14 June 2009.

  • Image Result

    Mechanisms for platelet activation: substances in the top of the figure correspond to the most common platelet activators that exert their mechanism attaching to specialized platelet surface receptors

    Mechanisms for platelet activation: substances in the top of the figure correspond to the most common platelet activators that exert their mechanism attaching to specialized platelet surface receptors. Pathway-specific platelet antagonists appear in red.

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01334-2

doi: 10.1016/j.jvs.2009.06.023

Journal of Vascular Surgery
Volume 50, Issue 6 , Pages 1500-1510 , December 2009

Article Tools

* Image Usage & Resolution